Invesco's RSPH or iShares' IBB: Which Healthcare ETF Is the Better Long-Term Buy?

Invesco S&P 500 Equal Weight Health Care ETF offers a lower expense ratio and a higher dividend yield than iShares Biotechnology ETF. iShares Biotechnology ETF provides concentrated biotech exposure while Invesco S&P 500 Equal Weight Health Care ETF covers the broader healthcare sector.

The Motley Fool • Oct 26, 2026

Which Healthcare ETF Is the Better Buy: Invesco's Broad RSPH or First Trust's Biotech FBT?

First Trust NYSE Arca Biotechnology Index Fund has delivered significantly higher 1-year total returns but with greater volatility and a deeper maximum drawdown. Invesco S&P 500 Equal Weight Health Care ETF provides broader sector coverage, whereas the First Trust fund is a concentrated play on 30 biotechnology firms.

The Motley Fool • Oct 26, 2026

S&P 500 Health Care ETF (RSPH) Touches New 52-Week High

RSPH hits a new 52-week high, rising 29.5% from its low as resilient healthcare demand, solid earnings and defensive-sector appeal fuel momentum.

Zacks Investment Research • Oct 15, 2026

From Laggard to Leader: The Surprising Comeback of Healthcare

Healthcare stocks have finally stepped back into the spotlight. After spending much of the past several years in the shadow of technology and AI, the sector has quietly emerged as one of the year's more compelling comeback stories.

ETF Trends • Oct 13, 2026

Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens

The Invesco S&P 500 Equal Weight Health Care ETF offers a lower expense ratio and broader diversification than the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF has generated higher 1-year and 5-year total returns while maintaining lower price volatility.

The Motley Fool • Oct 11, 2026

Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?

Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), a passively managed exchange traded fund launched on November 1, 2006.

Zacks Investment Research • Oct 5, 2026

PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors?

PBE offers a higher dividend yield and has delivered stronger one-year total returns. RSPH offers a more affordable expense ratio and a significantly lower historical drawdown.

The Motley Fool • Sep 15, 2026

Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.

The Invesco S&P 500 Equal Weight Health Care ETF provides broader exposure with 60 holdings compared to 26 for the VanEck Pharmaceutical ETF. The VanEck Pharmaceutical ETF currently offers a significantly higher dividend yield and a lower expense ratio than its counterpart.

The Motley Fool • Sep 11, 2026

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

The Invesco S&P 500 Equal Weight Health Care ETF (RSPH) was launched on 11/01/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

Zacks Investment Research • Aug 31, 2026

Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPH

The Invesco S&P 500 Equal Weight Health Care ETF provides broad exposure to the sector, while the State Street SPDR S&P Pharmaceuticals ETF focuses specifically on the pharmaceutical industry. The State Street SPDR S&P Pharmaceuticals ETF has significantly outperformed over the last year, though it carries higher concentration risk and historical volatility.

The Motley Fool • Aug 12, 2026